ライフサイエンスコーパス: ethics committee

1 This case-control study was approved by the local research ethics committee.

2 on of prospectively acquired data was approved by the local ethics committee.

3 Materials and Methods The study was approved by the local ethics committee.

4 ods This HIPAA-compliant study was approved by the regional ethics committee.

5 observational, longitudinal trial and approved by the local ethics committee.

6 Materials and Methods Approval was obtained from the local ethics committee.

7 d Methods The animal experiments were approved by the local ethics committee.

8 s retrospective analysis was approved by the local research ethics committee.

9 Each treatment was approved by the clinical ethics committee.

10 Following approval by the ethics committee, a long-term supplementation treatment was i

11 Retrospective evaluation of data was approved by the local ethics committee and informed consent was waived.

12 concerns were raised by the independent data monitoring and ethics committee and only five patients were withdrawn from d

13 is prospective case-control study was approved by the local ethics committee and the research department of Nottingham Un

14 nd Methods This study was approved by the national research ethics committee and was performed with informed consent.

15 ted with the approval of the Newcastle and North Tyneside 2 ethics committee and written consent.

16 Methods This retrospective study was approved by the local ethics committee and written informed consent was obtained fr

17 edefined and serious adverse events (SAEs) were reported to ethics committees and a central safety monitor.

18 ls and Methods The study was approved by the local research ethics committee, and all participants gave written informed

19 Materials and Methods The study was approved by the local ethics committee, and all subjects gave written informed cons

20 This retrospective study was approved by the institutional ethics committee, and informed consent was waived.

21 Materials and Methods The study was approved by a research ethics committee, and participants gave written informed cons

22 ective observational study was approved by an institutional ethics committee, and the need for patient consent was waived

23 ods Retrospective data evaluation was approved by the local ethics committee, and the requirement to obtain informed cons

24 ls and Methods This in vivo study was approved by the local ethics committee, and written informed consent was obtained f

25 takeholders, including researchers, regulatory authorities, ethics committees, and policymakers.

26 nd Methods This prospective study was approved by the local ethics committees, and written informed consent was obtained

27 Materials and Methods Institutional ethics committee approval and informed consent were obtained.

28 unteer study, performed between 2006 and 2016 with research ethics committee approval and written informed consent from e

29 Materials and Methods Institutional review board and local ethics committee approval and written informed consent were o

30 The protocol had the appropriate national research ethics committee approval for the countries where the study w

31 Materials and Methods Local ethics committee approval was obtained at all sites for this

32 ials and Methods Written informed consent and institutional ethics committee approval were obtained.

33 Materials and Methods This study had institutional ethics committee approval.

34 The institutional ethics committee approved the study and waived informed conse

35 Materials and Methods The institutional ethics committee approved the study and waived the requiremen

36 ll patients provided signed consent, and the local research ethics committee approved the study.

37 body weight) were retrospectively included in this regional ethics committee-approved study.

38 inflammatory bowel disease, and were judged by the medical ethics committee as not being related to the therapy.

39 Materials and Methods This study was approved by the local ethics committee at all participating sites.

40 (RCTs) based on archived protocols approved by six research ethics committees between 13 January 2000 and 25 November 200

41 r 2018 and June 2019 after receiving authorization from the ethics committee for health research.

42 This is not a conventional ethics committee, frequently giving rise to a board's bureauc

43 nce with relevant guidelines and regulations of the medical ethics committee in Hospital of Stomatology, Hebei Medical Un

44 e study was approved by the UK Ministry of Defence research ethics committee (MODREC 165/Gen/10 and 692/MoDREC/15).

45 ials and Methods This prospective study was approved by the ethics committee of the University Hospital of Munster (AZ 20

46 Retrospective data evaluation was approved by the local ethics committee of the University of Heidelberg (ethics appr

47 hods This prospective study was approved by the independent ethics committees of Kanton Bern and Kanton Zurich, and signe

48 Retrospective registration with local ethics committee on 21 March 2019.

49 The chair/director of each hospital's adult clinical ethics committee, or a suitable alternate representative fami

50 ive population-based cohort study was approved by a medical ethics committee overseen by the national government, and all